Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Will Spiraling Costs Retard Growth Of Clinical Research In India? The Jury Is Out

This article was originally published in PharmAsia News

Executive Summary

MUMBAI - From being a preferred destination for conducting clinical research to facing competitive pressure from countries like Malaysia, the Indian clinical research industry may miss the opportunity of emerging as a global hub for multinational drug companies
Advertisement

Related Content

Launching Clinical Trials In India? Beware Of Long Delays And New Mandates
Launching Clinical Trials In India? Beware Of Long Delays And New Mandates
Top Indian CROs Unite On Centralized Biometric Database Covering Trial Volunteers
Top Indian CROs Unite On Centralized Biometric Database Covering Trial Volunteers
Clinical Trial Activity In Emerging Markets Deemed Minor Against Global Backdrop - ACRO
Clinical Trial Activity In Emerging Markets Deemed Minor Against Global Backdrop - ACRO
Advertisement
UsernamePublicRestriction

Register

SC070038

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel